Improving Pancreatic Cancer Care by the Use of Computational Science and Technology

Abroad (travel likely)Recruiting

Conditions

Pancreatic Cancer · Pancreatic Cyst · Pancreatic Adenocarcinoma · Pancreatic Diseases · Pancreas Adenocarcinoma · Pancreas Cyst

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Regional Academic Cancer Center Utrecht, Utrecht, Netherlands
Contact: Study coordinator (Lois A Daamen, MD, PhD) · l.a.daamen-3@umcutrecht.nl · 0651223276

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

Borderline Resectable Pancreatic Ductal Adenocarcinoma · Resectable Pancreatic Adenocarcinoma · Stage I Pancreatic Cancer AJCC v8

Abroad (travel likely)RecruitingPHASE2

Atlanta, United States

Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study

Pancreatic Cancers · Pancreatic Diseases

Abroad (travel likely)Recruiting

Aurora, United States · Cleveland, United States

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Malignant Head and Neck Neoplasm · Malignant Neoplasm · Metastatic Malignant Neoplasm in the Neck

Abroad (travel likely)Recruiting

Houston, United States

Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer

Pancreatic Cancer, Adult

Abroad (travel likely)RecruitingPHASE3

Tianjin, China